AstraZeneca ties up with France\'s Transgene to develop viral immunotherapies

AstraZeneca ties up with France's Transgene to develop viral immunotherapies

British drugmaker AstraZeneca Plc and French biopharmaceutical firm Transgene SA entered into an agreement on Thursday to co-develop five cancer-killing viral immunotherapies.

More From BioPortfolio on "AstraZeneca ties up with France's Transgene to develop viral immunotherapies"